These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23948512)

  • 1. The burgeoning epidemic of morbid obesity in patients undergoing percutaneous coronary intervention: insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
    Buschur ME; Smith D; Share D; Campbell W; Mattichak S; Sharma M; Gurm HS
    J Am Coll Cardiol; 2013 Aug; 62(8):685-91. PubMed ID: 23948512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radial PCI and the obesity paradox: Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    McDonagh JR; Seth M; LaLonde TA; Khandewal AK; Wohns DH; Dixon SR; Gurm HS
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):211-9. PubMed ID: 26010906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-hospital outcomes of percutaneous coronary interventions in extremely obese and normal-weight patients: findings from the NCDR (National Cardiovascular Data Registry).
    Payvar S; Kim S; Rao SV; Krone R; Neely M; Paladugu N; Daggubati R
    J Am Coll Cardiol; 2013 Aug; 62(8):692-6. PubMed ID: 23948513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011.
    Dehmer GJ; Weaver D; Roe MT; Milford-Beland S; Fitzgerald S; Hermann A; Messenger J; Moussa I; Garratt K; Rumsfeld J; Brindis RG
    J Am Coll Cardiol; 2012 Nov; 60(20):2017-31. PubMed ID: 23083784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical outcomes of percutaneous coronary intervention performed without pre-procedural aspirin.
    Kenaan M; Seth M; Aronow HD; Wohns D; Share D; Gurm HS;
    J Am Coll Cardiol; 2013 Dec; 62(22):2083-9. PubMed ID: 24055844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preprocedural statin use in patients undergoing percutaneous coronary intervention.
    Kenaan M; Seth M; Aronow HD; Naoum J; Wunderly D; Mitchiner J; Moscucci M; Gurm HS;
    Am Heart J; 2014 Jul; 168(1):110-6.e3. PubMed ID: 24952867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registry.
    Duvernoy CS; Smith DE; Manohar P; Schaefer A; Kline-Rogers E; Share D; McNamara R; Gurm HS; Moscucci M
    Am Heart J; 2010 Apr; 159(4):677-683.e1. PubMed ID: 20362729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroperitoneal hematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality: a report from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registry.
    Trimarchi S; Smith DE; Share D; Jani SM; O'Donnell M; McNamara R; Riba A; Kline-Rogers E; Gurm HS; Moscucci M;
    JACC Cardiovasc Interv; 2010 Aug; 3(8):845-50. PubMed ID: 20723857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries.
    Yan BP; Clark DJ; Buxton B; Ajani AE; Smith JA; Duffy SJ; Shardey GC; Skillington PD; Farouque O; Yii M; Yap CH; Andrianopoulos N; Brennan A; Dinh D; Reid CM; ;
    Heart Lung Circ; 2009 Jun; 18(3):184-90. PubMed ID: 19268632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of body mass index to outcomes after percutaneous coronary intervention.
    Shubair MM; Prabhakaran P; Pavlova V; Velianou JL; Sharma AM; Natarajan MK
    J Interv Cardiol; 2006 Oct; 19(5):388-95. PubMed ID: 17020562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry.
    Lancefield T; Clark DJ; Andrianopoulos N; Brennan AL; Reid CM; Johns J; Freeman M; Charter K; Duffy SJ; Ajani AE; Proietto J; Farouque O;
    JACC Cardiovasc Interv; 2010 Jun; 3(6):660-8. PubMed ID: 20630460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing definition of contrast-induced nephropathy and its clinical implications: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    Slocum NK; Grossman PM; Moscucci M; Smith DE; Aronow HD; Dixon SR; Share D; Gurm HS
    Am Heart J; 2012 May; 163(5):829-34. PubMed ID: 22607861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in sex-related bleeding and outcomes after percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) registry.
    Othman H; Khambatta S; Seth M; Lalonde TA; Rosman HS; Gurm HS; Mehta RH
    Am Heart J; 2014 Oct; 168(4):552-9. PubMed ID: 25262266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity paradox in coronary artery bypass grafting: myth or reality?
    Benedetto U; Danese C; Codispoti M
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1517-23. PubMed ID: 23870152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry).
    Minutello RM; Chou ET; Hong MK; Bergman G; Parikh M; Iacovone F; Wong SC
    Am J Cardiol; 2004 May; 93(10):1229-32. PubMed ID: 15135694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of relationship between obesity and mortality or morbidity after coronary artery bypass grafting.
    Wang TK; Ramanathan T; Stewart R; Gamble G; White H
    N Z Med J; 2013 Nov; 126(1386):56-65. PubMed ID: 24316993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index, periprocedural bleeding, and outcome following percutaneous coronary intervention (from the British Columbia Cardiac Registry).
    Byrne J; Spence MS; Fretz E; Mildenberger R; Chase A; Berry B; Pi D; Janssen C; Klinke P; Hilton D
    Am J Cardiol; 2009 Feb; 103(4):507-11. PubMed ID: 19195511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary use and effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention.
    Gurm HS; Smith DE; Berwanger O; Share D; Schreiber T; Moscucci M; Nallamothu BK;
    JACC Cardiovasc Interv; 2012 Jan; 5(1):98-104. PubMed ID: 22230155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex difference in the effect of obesity on prognosis for patients undergoing percutaneous coronary intervention.
    Wang ZJ; Zhao YX; Liu YY; Shi DM; Gao F; Liu XL; Yu M; Zhou YJ
    Coron Artery Dis; 2012 Sep; 23(6):404-11. PubMed ID: 22828723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and cardiovascular thrombotic events in patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Nie B; Ge HL; Jia DA; Yang SW; Yan ZX
    Heart; 2009 Oct; 95(19):1587-92. PubMed ID: 19592387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.